Korean J Obstet Gynecol.  1999 Jul;42(7):1472-1477.

Serum Level of Interleukin-2 and Tumor Necrosis Factor-alpha in Normal Pregnant Woman

Abstract


OBJECTIVE
Because the fetus exists immunologically as a semiallograft, pregnancy loss may be a manifestation of host versus graft rejection in some cases. So we undertook a preliminary study to determine IL-2 and TNF-alpha levels in serum during normal pregnancy.
METHODS
Samples were taken for serum TNF-alpha and IL-2 enzyme linked immunosolvent assays [ELISA: R&D systems, Minneapolis, MN] from 50 pregnant women without any complications, 30 healthy non pregnant women and 5 women with at least two previous abortions between 6-14 weeks. 5 women had symptoms of an threatened abortions as evidenced by a vaginal bleeding and ultimately had a third abortion. Statistical analysis was used student t test.
RESULTS
Serum IL-2 levels were determined respectively 11.0 22.5pg/mL and 66.2 47.5pg/mL in control and normal pregnant women. The peak IL-2 level was reached as early as the first month and was stable during pregnancy. Serum TNF-alpha levels were determined respectively 11.6 28.1pg/mL and 11.4 21.8pg/mL in control and normal pregnant women. Serum TNF-alpha levels in women with unexplained recurrent abortion were 29-34pg/mL.
CONCLUSIONS
In normal pregnant women we found an increase in serum levels of IL-2 compared to the non-pregnant women. As regards serum levels of TNF-alpha, no differences could be observed between normal pregnant and non-pregnant women. In women with URA an increase in serum levels of TNF-alpha were found compared to the normal pregnant women.

Keyword

Unexplained recurrent abortion; Interleukin-2; Tumor necrosis factor-alpha

MeSH Terms

Abortion, Habitual
Abortion, Induced
Abortion, Threatened
Female
Fetus
Graft Rejection
Humans
Interleukin-2*
Pregnancy
Pregnant Women*
Tumor Necrosis Factor-alpha*
Uterine Hemorrhage
Interleukin-2
Tumor Necrosis Factor-alpha
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr